Table 2.
Comparison of clinical characteristics of two groups divided by cPCs.
| Variables | CPCs ≥0.165% (N=42) |
CPCs <0.165% (N=103) |
p-value |
|---|---|---|---|
| Male (N, %) | 24(57.1%) | 60(58.3%) | 0.902 |
| Age | 58(45, 72) | 58(31, 73) | 0.443 |
| ISS stage (N, %) stage I stage II stage III |
2(4.8%) 13(31.0%) 27(64.2%) |
24(23.3%) 50(48.5%) 29(28.2%) |
<0.001 |
| R-ISS stage (N, %) stage I stage II stage III |
1(2.4%) 21(50.0%) 20(47.6%) |
20(19.4%) 76(73.8%) 7(6.8%) |
<0.001 |
| Hemoglobin (g/L) | 77.2 ± 23.1 | 96.5 ± 23.3 | <0.001 |
| Platelet (×109) | 142.8 ± 62.5 | 182.8 ± 62.4 | 0.001 |
| Albumin (g/L) | 33.3 ± 7.3 | 33.8 ± 6.9 | 0.699 |
| Globulin (g/L) | 49.8(12.5, 125.8) | 43.7(14, 112.2) | 0.856 |
| LDH (u/L) | 166.6(90.2, 611.9) | 154.5(59.9, 458.2) | 0.160 |
| CCR: ml/(min×1.73m2) <40 ≥40 |
21(50.0%) 21(50.0%) |
26(25.2%) 77(74.8%) |
0.004 |
| Calcium (mmol/L) | 2.3(1.8, 3.6) | 2.2(1.8, 3.2) | 0.025 |
| β2-microglobulin (mg/L) | 7.3(2.3, 64.2) | 3.1(0.86, 39.0) | <0.001 |
| M-protein (g/L) | 25.7(0.23, 104.5) | 18.9(0.21, 86.5) | 0.318 |
| BMPC(%) | 55.5(10.0, 95.0%) | 22.0(10.0, 95.5) | <0.001 |
| FISH(N,%) High risk Standard risk |
18(42.9%) 24(57.1%) |
18(17.5%) 85(82.5%) |
0.001 |